Search
Menu
Home
HTB
2014
August
HTB
August 2014
Contents
Editorial
July/August 2014: Volume 15 Number 7/8
Conference reports
20th International AIDS Conference, 20-25 July 2014, Melbourne
The loss of friends and colleagues from flight MH 17
Higher ART coverage is associated with lower HIV infection rates in a multi-country analysis
Pill A, Pill B: simplified second-line treatment for low-income countries
UNAIDS sets 90-90-90 target for 2020 to end AIDS by 2030
No difference in overall anaemia rate with reduced dose AZT
Open label oral PrEP at four doses a week: why zero infections does not equal 100% efficacy
Cure research at IAS 2014: TILDA measures the reservoir and romidepsin wakes it up
HIV and transgender issues at AIDS 2014
Transgender services and clinics: interviews at AIDS 2014 with JoAnne Keatley and Beatriz Grinsztejn
Publications launched at AIDS 2014
6th International Workshop on HIV Paediatrics, 18-19 July 2014, Melbourne
Update on paediatric antiretrovirals
Is d4T a viable option for children in low-income countries?
3TC or FTC monotherapy suboptimal as a bridging strategy for adolescents
Rationalising the paediatric antiretroviral formulary in Malawi
Time to first-line failure in the IeDEA cohort
Influence of early ART on antibody detection in children
8th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-Poor Settings (INTEREST), 5-6 May 2014, Lusaka, Zambia
Short-term safety of atazanavir/ritonavir-based second line treatment in Zambia
Pregnancy outcomes in Zambia
Uptake of ART is influenced by distance to the health facility in rural Zambia
Genotyping using dried blood spots in rural South African setting
Antiretrovirals
Dolutegravir-based single-tablet regimen set for EU approval
Treatment access
New ARV prescribing guidelines for London (2014)
Paediatric care
Wrestling with the implications of the Mississippi case
Guidelines
WHO guidelines for key populations (July 2014): gay men, people who inject drugs, people in prisons, sex workers, transgender people
EASL update guidelines for hepatitis C (April 2014)
Side effects
Bone mineral density linked to inflammatory markers in HIV positive people who are ART naïve
Hepatitis coinfection
US Senate investigate Gilead for sofosbuvir price: potential to bankrupt Federal healthcare and add $300 annually to every American insurance premium for the next five years
Cure-related research
Effects of long-term ART initiated during primary HIV infection on reservoir size
Basic science and immunology
Molecular events in HIV neutralising antibody development
On the web
Community reports and briefings
Online journals
PDFs
Volume 15 Number 7/8 July/August 2014 PDF
HTB RSS
Early access
Future PrEP and updated lenacapavir studies with case details from PURPOSE 2
21 November 2024
Glasgow HIV Congress 2024
10 November 2024
Unheard: The medical practice of silencing – by Dr Rageshri Dhairyawan
9 November 2024
Bipolar disorder in people living with HIV
1 November 2024
All early access reports
Current issues
November 2024
October 2024
September 2024
Back issues
Special report
HTB news: i-Base changes during 2024
1 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate